Interpreting a hard-won structure of the arenavirus prefusion glycoprotein
Interpreting a hard-won structure of the arenavirus prefusion glycoprotein
批准号:
8973536
负责人:
Erica Ollmann Saphire
金额:
$23.69万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-12-01 至 2017-11-30
关键词:
AcidsAcuteAffinityAntibodiesArchitectureArenavirusBindingBinding SitesBolivian Hemorrhagic Fever VirusCarbohydratesCategoriesCellsCleaved cellComplexCongenital AbnormalityDataDeuteriumDiseaseDystroglycanEncephalitisEpitopesFaceFamilyGP2 geneGTPBP1 geneGlycoproteinsGuanarito virusHealthHumanImmunobiologyImmunotherapeutic agentInfectionJunin virusLaboratoriesLaboratory StudyLassa virusLinkLocationLujo virusLymphocytic choriomeningitis virusMapsMass Spectrum AnalysisMediatingMembraneMembrane GlycoproteinsModelingMolecular ConformationMutagenesisMutationOld World ArenavirusesPathogenicityPeptide Signal SequencesPoint MutationProteinsResearchShapesStructureSurfaceSurvivorsTFRC geneTacaribe Complex VirusesTropismVaccine DesignVaccinesViralViral AntibodiesViral Hemorrhagic FeversVirusVirus Diseasesalpha Dystroglycanneutralizing antibodynovelpathogenreceptorreceptor bindingtherapeutic vaccine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The arenavirus family includes >50 known viruses, including both severe human pathogens and laboratory models such as lymphocytic choriomeningitis virus (LCMV). All of the Old World arenaviruses and some of the New World arenaviruses use alpha- dystroglycan as a cellular receptor. This molecule is bound by the single glycoprotein expressed on the viral surface, termed GP. GP thus mediates attachment, fusion and entry into host cells, and also determines tropism and often, pathogenicity. Understanding the structure of GP, especially the structure of oligomeric, prefusion GP as it exists on the viral surface, is essential to understanding virus entry and tropism and to developing vaccines, antibodies, and antivirals. However, no structure yet exists for any prefusion GP of any arenavirus. Further, no structure yet exists for the GP1 receptor-binding subunit of GP for any arenavirus that uses alpha-dystroglycan as a receptor. In our preliminary data, we describe our newly determined, hard-won crystal structure of the fully glycosylated, prefusion arenavirus GP from the α-dystroglycan- binding Old World virus LCMV. This LCMV GP ectodomain forms a trimer in the crystals. In Aim 1, we propose to determine if this arrangement represents the biologically relevant trimer on the surface of arenaviruses. In Aim 2, we propose to map the α- dystroglycan-binding site of the Old World arenavirus GP. An R21 is intended for novel studies that break new ground and extend previous results in new directions. The research proposed here will indeed provide transformative models for understanding assembly and entry of this very large family of human pathogens. It will also provide new templates for design of vaccines, therapeutics, and immunotherapeutic cocktails. Aim1 will provide the first biologically supported model of prefusion, oligomeric GP, which is likely applicable to the entire arenavirus family. Aim 2 will elucidate the receptor-binding site for the many Old World arenaviruses and those of clade C New World arenaviruses as well. Aim 2 will also provide templates for understanding viral tropism, and will explain historical mutations that determine disease course and that have been used extensively to illuminate virus immunobiology.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Structure of the SARS-CoV-2 Nucleocapsid: building block to viral capsid
-
批准号:10728253
-
项目类别:
-
资助金额:$28.59万
-
财政年份:2023
-
负责人:Erica Ollmann Saphire
-
依托单位:
Integrative Immunogen Design and Testing
-
批准号:10842890
-
项目类别:
-
资助金额:$206.09万
-
财政年份:2021
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics against Emerging Viral Threats
-
批准号:10447562
-
项目类别:
-
资助金额:$190.37万
-
财政年份:2021
-
负责人:Erica Ollmann Saphire
-
依托单位:
Integrative Immunogen Design and Testing
-
批准号:10328121
-
项目类别:
-
资助金额:$262.89万
-
财政年份:2021
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics against Emerging Viral Threats
-
批准号:10199909
-
项目类别:
-
资助金额:$268.88万
-
财政年份:2020
-
负责人:Erica Ollmann Saphire
-
依托单位:
Administrative Core
-
批准号:10158452
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics against Emerging Viral Threats
-
批准号:9924443
-
项目类别:
-
资助金额:$714.34万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
-
批准号:10402338
-
项目类别:
-
资助金额:$220.97万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
-
批准号:10158448
-
项目类别:
-
资助金额:$222.22万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
-
批准号:10617736
-
项目类别:
-
资助金额:$227.09万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Administrative Core
-
批准号:10617743
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics against Emerging Viral Threats
-
批准号:10158446
-
项目类别:
-
资助金额:$706.53万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics against Emerging Viral Threats
-
批准号:10617733
-
项目类别:
-
资助金额:$700.63万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Administrative Core
-
批准号:10402342
-
项目类别:
-
资助金额:$32.81万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics against Emerging Viral Threats
-
批准号:10402336
-
项目类别:
-
资助金额:$702.08万
-
财政年份:2019
-
负责人:Erica Ollmann Saphire
-
依托单位:
Function and assembly of the Ebola virus nucleocapsid
-
批准号:9228308
-
项目类别:
-
资助金额:$50.37万
-
财政年份:2016
-
负责人:Erica Ollmann Saphire
-
依托单位:
Function and assembly of the Ebola virus nucleocapsid
-
批准号:9127650
-
项目类别:
-
资助金额:$50.37万
-
财政年份:2016
-
负责人:Erica Ollmann Saphire
-
依托单位:
Function and assembly of the Ebola virus nucleocapsid
-
批准号:10065819
-
项目类别:
-
资助金额:$22.7万
-
财政年份:2016
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers
-
批准号:8642293
-
项目类别:
-
资助金额:$599.76万
-
财政年份:2014
-
负责人:Erica Ollmann Saphire
-
依托单位:
Consortium for Immunotherapeutics Against Viral Hemorrhagic Fevers
-
批准号:9231360
-
项目类别:
-
资助金额:$608.43万
-
财政年份:2014
-
负责人:Erica Ollmann Saphire
-
依托单位:
海外基金